ArticleCancer immunology, immunotherapy : CII2013

Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity.

Sharon H Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.